Fairfield Financial Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-75
Closed -$6.76K 207
2024
Q4
$6.76K Hold
75
﹤0.01% 216
2024
Q3
$7.42K Sell
75
-8
-10% -$786 ﹤0.01% 234
2024
Q2
$7.71K Buy
+83
New +$7.44K ﹤0.01% 226
2023
Q4
$7.41K Hold
83
﹤0.01% 255
2023
Q3
$6.06K Hold
83
﹤0.01% 250
2023
Q2
$6.91K Sell
83
-100
-55% -$8.36K ﹤0.01% 261
2023
Q1
$13.7K Hold
183
0.01% 216
2022
Q4
$15.2K Sell
183
-692
-79% -$56K 0.01% 186
2022
Q3
$69.4K Hold
875
0.03% 100
2022
Q2
$65K Sell
875
-616
-41% -$46.2K 0.03% 101
2022
Q1
$134K Buy
+1,491
New +$138K 0.05% 74

Other funds holding XBI